Search results

The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.

ANSTO providing support to emergency services, closed to non-essential staff.

ANSTO is a major supplier of Australia’s radioactive isotopes used in nuclear medicine, delivering around 10,000 patient doses each week.  Health-based research and development in Australia and overseas also benefit greatly from ANSTO’s unique capabilities and expertise in the detection, diagnosis and treatment of disease using nuclear and accelerator infrastructure.​

Research has demonstrated that internally generated neutrons could be used to effectively target micro-infiltrates and cancer cells outside of the defined treatment regions.

Research to improve knowledge of natural variability in rainfall and recharge by monitoring hydrological processes in key regions and reconstruct water recharge history.

Australian clean energy technology company, entX Limited is taking advantage of ANSTO’s unique capacity to generate tailored radioisotope products in the OPAL multi-purpose nuclear reactor to advance a series of innovative projects.

Nuclear safety expert discusses Fukushima

Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.

Just under 250 schools in Australia and one school in Malaysia will participate in a series of science-based competitions during to coincide with National Science Week in 2024.

Five exceptional female science communicators are part of a larger team who use skills in education and engagement to promote an interest in science amongst the public and students.

Environmental researcher joins Science & Technology Australia as Cluster representative for the Chemical Sciences